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Introduction
Taybi–Linder syndrome or microcephalic osteodysplastic
primordial dwarfism type 1 (MOPD1) (MIM # 210710) is
a rare autosomal recessive developmental disorder, ori-
ginally described in 1967 (Taybi and Linder, 1967). The
patients present with severe intrauterine and postnatal
growth retardation, microcephaly, facial dysmorphism,
sparse thin hair and dry skin (Meinecke and Passarge,
1991). Radiological findings include dysplasia of the
skeleton with cleft vertebral arches, horizontal acetabula
and short and bowed long bones (Sigaudy et al., 1998).
Neurological findings typically include profound devel-
opmental delay, blindness, hearing deficits, central ner-
vous system malformations, early-onset epilepsy and
neuroendocrine dysfunction (Pierce and Morse, 2012).
MOPD1 has been shown to result from biallelic muta-
tions in the RNU4ATAC gene encoding the small nuclear
RNA (snRNA) U4atac, which is a component of the
minor spliceosome. Although accounting for splicing of
only about 800 introns, the minor spliceosome is involved
in the correct splicing of many essential gene products.
Thus, minor intron splicing has a critical role in human
development (He et al., 2011).
At present, only around 40 patients with MOPD1 and 10
different RNU4ATAC mutations have been reported
according to the Human Gene Mutation Database. The
condition is usually severe, and the patients do not
generally live beyond the age of 3 years (Meinecke and
Passarge, 1991). A few cases with a slightly milder phe-
notype have been reported (Abdel-Salam et al., 2012;
Nagy et al., 2012), but no patients have yet been reported
to survive into adulthood.
We report on two adult siblings with MOPD1 presenting
with an atypical mild phenotypic appearance compared
with the previously reported cases.
Clinical reports
The two siblings are the second and third children of
healthy nonconsanguineous white parents and have an
unremarkable family history. They both presented with
prenatal and postnatal growth retardation, microcephaly,
developmental delay, cataract, hearing loss and dysmorphic
features. Before the establishment of the diagnosis, the
cases were reported as unsolved cases (Hansen et al., 2009).
Case 1
A girl, now age 24 years, was born at 38 weeks of gesta-
tional age with a birth weight of 1950 g (− 3 SD), a length
of 43 cm (− 4 SD) and a head circumference of 29 cm
(− 5 SD). She had neonatal hypoglycaemia, which
resolved after treatment. In childhood, her skin was
affected by severe atopic dermatitis and she had allergies
towards egg, milk, nuts and grass. She had several pul-
monary infections in early childhood and asthma until
10 years of age. The dysmorphic features included
receding forehead, large prominent eyes, arched eye-
brows, hypoplasia of the ala nasi, micrognathia, thin hair,
small low-set ears and short neck (Fig. 1a and b). Dental
examination revealed malocclusion, crowded teeth and
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microdontia with enamel abnormalities. She had tapering
fingers and her fingers and toes were broad and short, the
skin was dry and the nails were dystrophic (Fig. 1c
and d). Radiographs of the long bones, at the age
of 1 and 8 years, displayed generalized shortening
with metaphyseal broadening and delayed bone age.
Ophtalmological examination revealed bilateral cataracts,
which were operated at the age of 5 years, and tapeto-
retinal degeneration. She had menarche at 16 years of age
and had normal periods. From the age of 14 years, she
had progressive sensorineural hearing loss of 60 dB, par-
tially corrected by hearing aids. At the age of 23 years, she
developed severe pneumonia complicated by haemolytic
uraemic syndrome and required respiratory support and
dialysis for 1 week. Cranial MRI at the age of 24 years
demonstrated microcephaly, partial agenesis of corpus
callosum and general atrophy. She did not develop epi-
lepsy. At the most recent evaluation, at the age of
24 years, she was severely growth retarded with a height
of 142 cm (− 5 SD), weight of 35 kg (− 6 SD) and a head
circumference of 45 cm (− 10 SD). Intellectual disability
was evident with an IQ of 56, but she was able to live in
her own apartment with some support. She had reading
skills comparable with a 9-year-old and very limited
mathematics skills. She had a slight kyphosis, but no
specific orthopaedic problems and was able to walk 5 km.
Case 2
A boy, now aged 17 years, presented like his sister with
severe prenatal growth retardation and was delivered at
Fig. 1
Case 1, age 24 years. (a, b) Dysmorphic features included receding forehead, prominent eyes, arched eyebrows, hypoplasia of the ala nasi,
micrognathia, thin hair, small low-set ears and short neck. (c, d) Tapering fingers. Fingers and toes were broad and short, the skin was dry and nails
were dystrophic.
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32 weeks of gestation by Caesarean section with a birth
weight of 1079 g (− 4 SD) and length of 38 cm (− 4 SD).
He had atopic dermatitis and allergies in childhood. He
was operated on for cryptorchidism. He developed
bilateral cataract and received artificial lenses at the age
of 4 years, and ophthalmological examination has also
revealed tapetoretinal degeneration. He had asthma until
10 years of age. From the age of 10 years, he developed
progressive sensorineural hearing loss relieved by hearing
aids. The dysmorphic features included receding fore-
head, bulbous nose, hypoplasia of the ala nasi, full lips,
small ears and mild micrognathia (Fig. 2a and b). Dental
examination revealed malocclusion and small, crowded
teeth with enamel abnormalities. He had tapering fin-
gers, which were broad and short. He had flat feet, syn-
dactyly of second and third toes and dry skin (Fig. 2c
and d). Skeletal radiological examination at the age of
12 years (Fig. 3a and b) showed shortening of the long
bones, metaphyseal broadening, but otherwise relatively
normal configuration. He reached puberty at the age of
15 years. He did not develop epilepsy. At the most recent
evaluation, at the age of 17 years, he was severely growth
retarded with a height of 139 cm (− 7 SD), weight of
30 kg (− 6.5 SD) and a head circumference of 46.9 cm
(− 8 SD). He lived in his parents’ home, attended special
school and had reading capability corresponding to
Fig. 2
Case 2, age 17 years. (a, b) Dysmorphic features included receding forehead, bulbous nose, hypoplasia of the ala nasi, full lips, small ears and mild
micrognathia. (c, d) Tapering fingers, which were broad and short. The feet were flat with dry skin and short toes with syndactyly of second and
third toes.
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8 years of age, and no mathematics skills. He had good
motor skills, could ride a bicycle, walk 5–10 km and run
3 km without breaks.
Mutation analysis
The study was approved by the Scottish Multicentre
Research Ethics Committee (04:MRE00/19). Genomic
DNA samples from the patients, parents and unaffected
sister were analysed at the Institute of Genetics and
Molecular Medicine, University of Edinburgh, UK. The
RNU4ATAC gene was screened by bidirectional Sanger
sequencing, and analyses were performed using
Mutation Surveyor (Softgenetics Inc., Pennsylvania,
USA). The findings were validated by bidirectional
Sanger sequencing at the Department of Clinical
Genetics, Odense University Hospital, using SeqMan
Pro v.12.0, DNA Star (Wisconsin, USA).
The affected siblings were compound heterozygous for a
n.40C>T nucleotide substitution and an 85-base tan-
dem duplication (bp 16–100) in RNU4ATAC, which
results in an insertion of an 85-base-pair-long sequence in
position n.101.
The parents were both heterozygous for each one of
these mutations, and the oldest sister, who was unaf-
fected, was heterozygous for the n.40C>T mutation.
Neither of these mutations have been previously repor-
ted in the literature in relation to MOPD1. The
n.40C>T was reported in a single individual from south
Asia in the Exome Aggregation Consortium correspond-
ing to a population frequency of 0.0093%. No homo-
zygotes for the mutation have been detected.
Figure 4 displays the normal configuration of the U4atac
snRNA and localization of the two mutations. The
n.40C>T mutation is predicted to disrupt the essential
5′ stem loop, as the n.40C is one of four bases stabilizing
this loop and notably it pairs with n.46 G, a base pre-
viously reported to be mutated in MOPD1 (Kilic et al.,
2015). The other mutation, the 85-base-pair insertion in
position n.101, is also predicted to have a major impact on
conformation and to destroy the 3’ stem loop, and it is
therefore also predicted to have a major functional impact
on the snRNA [in-silico predictions made by Protein
Data Bank 3SIU (New Jersey, USA) and PhyMol v.1.7
(Schrödinger, New York, USA) software].
Discussion
MOPD1 is generally described as a fatal condition within
the first months or years of life. However, reports of less
severely affected individuals are emerging (Abdel-Salam
et al., 2012; Nagy et al., 2012).
Most of the previously reported cases were homozygous
for the n.51 G>A mutation, a founder mutation in the
Amish population, representing the most frequent geno-
type of MOPD1 patients and one associated with a
shorter life span compared with other cases (Nagy et al.,
2012). A patient described with a milder phenotype is
compound heterozygous for n.66C>G and n.124 G>A
mutations (Abdel-Salam et al., 2012). Thus, the fact that
our cases present with a mild phenotype may be because
of the compound heterozygous state or that one of the
mutations lies outside the essential 5′ stem loop.
Seven of the previously reported mutations in patients
with MOPD1 including n.30 G>A, n.46 G>A, n.50
G>A, n.50 G>C, n.51 G>A, n.53C>G and n. 55 G>A
mutations are located within the 5′ stem loop of the
U4atac snRNA, a motif interacting with spliceosomal
proteins. This secondary structure of the snRNA is highly
conserved across species, suggesting that the site is of
critical importance for minor U12 spliceosomal function
(Edery et al., 2011). The 3′ stem loop is also believed to
have an essential role, and complete deletion of the 3′
stem loop is reported to abolish the in-vivo splicing
function of the minor spliceosome (Shukla et al., 2002).
Fig. 3
Radiographs of (a) humerus and (b) femur of case 2 at the age of 12 years showing shortening of the long bones, metaphyseal broadening, but
otherwise relatively normal configuration.
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The two mutations reported by us are both predicted by
in-silico prediction tools to severely affect the secondary
structure of the snRNA.
Our presented cases display some classical features of
MOPD1, including prenatal and postnatal growth retard-
ation, microcephaly, developmental delay, cataract,
hearing loss and dysmorphic features, but unlike pre-
viously reported cases have survived into adult life.
Although no clear genotype–phenotype correlation exists
on the limited number of milder cases reported pre-
viously and in our study, our findings at least indicate that
the compound heterozygous genotype n.40C>T/n.101
tandem duplication (bp 16–100) in RNU4ATAC results in
a mild phenotypic appearance of MOPD1 compatible
with survival into adulthood. The presented cases further
expand the mutational and phenotypic spectrum of the
MOPD1 syndrome.
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Schematic of the normal structure of the U4atac snRNA in complex with the other essential component of the minor spliceosome, U6atac. The
reported cases are compound heterozygous for two mutations in RNU4ATAC encoding U4atac (marked in red). The n.40C> T is predicted to
destroy the essential 5′ stem loop as the n.40C is one of four bases stabilizing this essential loop. The n.101 tandem duplication (bp16–100) is
predicted by in-silico prediction tools to induce a major conformational change and to destroy the 3′ stem loop. The positions of previously reported
mutations in patients with MOPD1 (marked by green dots) are also primarily situated in either the 5′ stem loop or the 3′stem loop.
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